PS Ratio
2.67
-0.02-0.74%
18 min ago
Summary
- As of February 26, 2025, BRNS price to sales ratio is 2.67, with a fall of -0.02 (-0.74%) during the most recent trading day.
- BRNS PS ratio is now -99.84% below its all-time high of 1630.47.
Performance
BRNS PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
PS Ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
BRNS PS Ratio Trends
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | -0.7% | -0.8% | -0.8% | - |
| 1 m1 month | -1.5% | -1.8% | -1.8% | - |
| 3 m3 months | +2.7% | +2.7% | +2.7% | 0.0% |
| 6 m6 months | - | -14.5% | -12.8% | - |
| ytdytd | -17.1% | -17.3% | -17.3% | - |
| 1 y1 year | - | -63.1% | -61.6% | 0.0% |
| 5 y5 years | - | - | - | +288.3% |
BRNS PS Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -11.3% | 2.50 | +6.8% | |
| 3 m | 3-month | 3.33 | -19.8% | 2.20 | +21.4% |
| 6 m | 6-month | 4.08 | -34.6% | 2.20 | +21.4% |
| 1 y | 1-year | 4.08 | -34.6% | 2.20 | +21.4% |
| 3 y | 3-year | 969.96 | -99.7% | 1.75 | +52.6% |
| 5 y | 5-year | 1630.47 | -99.8% | 1.75 | +52.6% |
| alltime | all time | 1630.47 | -99.8% | 1.75 | +52.6% |
Barinthus Biotherapeutics PS Ratio History
| Date | Value |
|---|---|
| 2025 | 2.67(-17.1%) |
| 2024 | 3.22(+62.6%) |
| Date | Value |
|---|---|
| 2022 | 1.98(-99.9%) |
| 2021 | 1541.67 |
FAQ
- What is Barinthus Biotherapeutics price to sales ratio?
- What is the all time high PS ratio for Barinthus Biotherapeutics?
- What is BRNS price to sales ratio year-to-date change?
What is Barinthus Biotherapeutics price to sales ratio?
The current PS ratio of BRNS is 2.67
What is the all time high PS ratio for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high price to sales ratio is 1630.47
What is BRNS price to sales ratio year-to-date change?
Barinthus Biotherapeutics price to sales ratio has changed by -0.55 (-17.08%) since the beginning of the year